December 16, 2025
According to market projections, small molecule inhibitor market was valued at USD 310.38 billion in 2025 and is expected to reach USD 328.22 billion by 2026, further expanding to around USD 542.87 billion by 2035, growing at a CAGR of 5.75% from 202...
November 13, 2025
According to market projections, the small molecule API sector is expected to grow from USD 206.9 billion in 2025 to USD 374.03 billion by 2035, reflecting a CAGR of 6.1%. The small molecule API market is growing due to rising investment by key playe...
December 29, 2025
The GLP-1 small molecule market covers comprehensive insights on global market size, segmentation, regional performance, and competitive dynamics across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market ...
November 01, 2025
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the ...
February 11, 2026
According to our projections, the global small molecule CMC service market was valued at USD 801.3 million in 2025 and reached USD 831.35 million in 2026, and it is projected to expand to approximately USD 1,157.91 million by 2035, growing at a CAGR ...
February 27, 2026
Our projections indicate, the small molecule CMO and CDMO market was valued at USD 75.8 billion in 2025 and is projected to grow from USD 79.7 billion in 2026 to USD 125.13 billion by 2035, expanding at a CAGR of 5.14% during 2026–2035....
February 23, 2026
Based on our estimations, the U.S. small molecule innovator API CDMO market was valued at USD 9.37 billion in 2025 and reached USD 9.94 billion in 2026, and is projected to grow to USD 16.85 billion by 2035, expanding at a CAGR of 6.04% from 2026 to ...
November 01, 2025
The small molecules market is growing as it is used in drug discovery, cancer therapies, neurological disorders, and cellular therapeutics, as it has a variety of biological functions. North America is dominant in the market due to increasing signifi...
November 01, 2025
Projections indicate that, small nucleic acid drug industry is projected to rise from USD 5.94 billion in 2024 to USD 33.28 billion by 2034, reflecting a CAGR of 18.84% over the next decade. The rising prevalence of chronic disorders and the growing ...
January 07, 2026
Market insights predict the global small scale bioreactors industry will increase from USD 2.63 billion in 2025 to USD 10.49 billion by 2035, achieving a CAGR of 14.84%. The growing demand for biopharmaceuticals and technological advancements drives ...
November 01, 2025
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 21.5 billion in 2024 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding d...
November 01, 2025
Market insights predict the global non-small lung carcinoma industry will increase from USD 9.1 billion in 2024 to USD 23.67 billion by 2034, achieving a CAGR of 10.03%. Clinical research, development of new treatment options, and prevalence of NSCLC...
October 24, 2025
The IVD diagnostic molecule raw enzymes market is valued at USD 2.39 billion in 2024, projected to reach USD 4.73 billion by 2034 at a 7.13% CAGR. It includes segmentation by enzyme type, application, and technology, with leading regions like North A...
December 02, 2025
The molecule therapeutics market is growing due to the field of molecular therapeutics is significant in medicine and human biology, as it provides novel information on the discovery, diagnosis, and treatment of present and emerging diseases....
January 21, 2026
Based on our market forecasts, the hemophilia inhibitors sector will expand from USD 16.43 billion in 2025 to USD 29.54 billion by 2035, experiencing a CAGR of 6.04%....
February 04, 2026
According to market research studies, the global oral Factor Xa inhibitors market was valued at USD 21.5B in 2023 and is projected to reach USD 41.24B by 2034, growing at a CAGR of 6.1%, driven by rising cardiovascular cases, ease of use, and incre...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
November 01, 2025
According to research analysis, the global Factor Xa inhibitors market, valued at US$ 22.1 billion in 2023, is projected to reach US$ 41.52 billion by 2034, driven by rising cardiovascular diseases. North America leads, while Asia-Pacific shows fas...
November 01, 2025
According to market projections, the CDK4/6 inhibitors sector is expected to grow from USD 11.38 billion in 2024 to USD 46.96 billion by 2034, reflecting a CAGR of 15.34%. The rising prevalence of cancer and growing research and development activit...
November 01, 2025
Projections indicate that, the global hematologic malignancies treatment market increased from USD 67.32 billion in 2024 to USD 139.13 billion by 2034, experiencing a CAGR of 7.61% over the next 10 years.The global rise in the elderly population, w...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com